| Human papillomavirus and survival of patients with oropharyngeal cancer KK Ang, J Harris, R Wheeler, R Weber, DI Rosenthal, PF Nguyen-Tân, ... New England Journal of Medicine 363 (1), 24-35, 2010 | 6875 | 2010 |
| Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck JA Bonner, PM Harari, J Giralt, N Azarnia, DM Shin, RB Cohen, CU Jones, ... New England Journal of Medicine 354 (6), 567-578, 2006 | 6418 | 2006 |
| Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash … JA Bonner, PM Harari, J Giralt, RB Cohen, CU Jones, RK Sur, D Raben, ... The lancet oncology 11 (1), 21-28, 2010 | 2424 | 2010 |
| Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (# 22931) and … J Bernier, JS Cooper, TF Pajak, M Van Glabbeke, J Bourhis, A Forastiere, ... Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2005 | 1857 | 2005 |
| A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation … KK Fu, TF Pajak, A Trotti, CU Jones, SA Spencer, TL Phillips, AS Garden, ... International Journal of Radiation Oncology* Biology* Physics 48 (1), 7-16, 2000 | 1666 | 2000 |
| Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma KK Ang, BA Berkey, X Tu, HZ Zhang, R Katz, EH Hammond, KK Fu, ... Cancer research 62 (24), 7350-7356, 2002 | 1634 | 2002 |
| Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis M Machtay, J Moughan, A Trotti, AS Garden, RS Weber, JS Cooper, ... Journal of Clinical Oncology 26 (21), 3582, 2008 | 1442 | 2008 |
| Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis J Bourhis, J Overgaard, H Audry, KK Ang, M Saunders, J Bernier, ... The Lancet 368 (9538), 843-854, 2006 | 1269 | 2006 |
| An epithelial–mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor … LA Byers, L Diao, J Wang, P Saintigny, L Girard, M Peyton, L Shen, Y Fan, ... Clinical cancer research 19 (1), 279-290, 2013 | 1003 | 2013 |
| Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival HT Hoffman, K Porter, LH Karnell, JS Cooper, RS Weber, CJ Langer, ... The Laryngoscope 116 (S111), 1-13, 2006 | 897 | 2006 |
| Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system JL Barker Jr, AS Garden, KK Ang, JC O'Daniel, H Wang, LE Court, ... International Journal of Radiation Oncology* Biology* Physics 59 (4), 960-970, 2004 | 844 | 2004 |
| Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522 KK Ang, Q Zhang, DI Rosenthal, PF Nguyen-Tan, EJ Sherman, RS Weber, ... Journal of clinical oncology 32 (27), 2940, 2014 | 834 | 2014 |
| CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines V Grégoire, P Levendag, KK Ang, J Bernier, M Braaksma, V Budach, ... Radiotherapy and oncology 69 (3), 227-236, 2003 | 832 | 2003 |
| Validation of an accelerated ‘demons’ algorithm for deformable image registration in radiation therapy H Wang, L Dong, J O'Daniel, R Mohan, AS Garden, KK Ang, DA Kuban, ... Physics in Medicine & Biology 50 (12), 2887, 2005 | 826 | 2005 |
| Radiation response of the central nervous system TE Schultheiss, LE Kun, KK Ang, LC Stephens International Journal of Radiation Oncology* Biology* Physics 31 (5), 1093-1112, 1995 | 811 | 1995 |
| Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225 N Lee, J Harris, AS Garden, W Straube, B Glisson, P Xia, W Bosch, ... Journal of clinical oncology 27 (22), 3684, 2009 | 789 | 2009 |
| Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer KK Ang, A Trotti, BW Brown, AS Garden, RL Foote, WH Morrison, ... International Journal of Radiation Oncology* Biology* Physics 51 (3), 571-578, 2001 | 713 | 2001 |
| Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation X Huang, L Ding, KL Bennewith, RT Tong, SM Welford, KK Ang, M Story, ... Molecular cell 35 (6), 856-867, 2009 | 704 | 2009 |
| In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody L Milas, K Mason, N Hunter, S Petersen, M Yamakawa, K Ang, ... Clinical cancer research 6 (2), 701-708, 2000 | 662 | 2000 |
| Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial LJ Peters, H Goepfert, KK Ang, RM Byers, MH Maor, O Guillamondegui, ... International Journal of Radiation Oncology* Biology* Physics 26 (1), 3-11, 1993 | 637 | 1993 |
Walter CurranGlobal Chief Medical Officer, GenesisCareVerifierad e-postadress på genesiscare.com
